首页 / 院系成果 / 成果详情页

Astegolimab for Chronic Obstructive Pulmonary Disease (COPD) in Patients With a History of Frequent Exacerbations: The Phase III, Randomized, Double-blind, Placebo-controlled, Multicenter ARNASA Trial  会议论文  

  • 编号:
    F1CD7C3C8460CA5875C4EED4B15AB7B4
  • 作者:
    Papi, A.[1] Wedzicha, J. A.[2] Roche, N.[3] Han, M. K.[4] Bhatt, S. P.[5] Shibata, Y.[6] Yang, T.[7] Porpodis, K.[8] Devine, J.[9] Zhang, W.[9] Gordon, O.[10] Saenz, R.[9] Yang, X.[9] Mohan, D.[9] Vogelmeier, C. F.[11] Brightling, C. E.[12]
  • 语种:
    英文
  • 会议名称:
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
  • 收录:
  • 推荐引用方式
    GB/T 7714:
    Papi A.,Wedzicha J. A.,Roche N., et al. Astegolimab for Chronic Obstructive Pulmonary Disease (COPD) in Patients With a History of Frequent Exacerbations: The Phase III, Randomized, Double-blind, Placebo-controlled, Multicenter ARNASA Trial [J].AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE,2026,212.
  • APA:
    Papi A.,Wedzicha J. A.,Roche N.,Han M. K.,&Brightling C. E..(2026).Astegolimab for Chronic Obstructive Pulmonary Disease (COPD) in Patients With a History of Frequent Exacerbations: The Phase III, Randomized, Double-blind, Placebo-controlled, Multicenter ARNASA Trial .AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE,212.
  • MLA:
    Papi A., et al. "Astegolimab for Chronic Obstructive Pulmonary Disease (COPD) in Patients With a History of Frequent Exacerbations: The Phase III, Randomized, Double-blind, Placebo-controlled, Multicenter ARNASA Trial" .AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE 212(2026).
  • 入库时间:
    2026/5/27 18:49:38
  • 更新时间:
    2026/5/27 18:49:38
浏览次数:9 下载次数:0
浏览次数:9
下载次数:0
打印次数:0
浏览器支持: Google Chrome   火狐   360浏览器极速模式(8.0+极速模式) 
返回顶部